Presented
by

Presented by Oxford Global

Member Login
|
Become a Member

Next Up

Antibody Engineering: Online

27 - 29 June 2022 |

Online: BST (UTC+1)

27 - 29 June 2022

Online: BST (UTC+1)

A focused 3-day meeting that delves into emerging technologies in antibody-based molecular engineering, novel & difficult targets, antibody-based therapeutics & a meeting place for experts working within engineering, computational tools and biotherapeutics. 

> Visit Event Website

19 May 2022
Thu, 19 May 2022

Infectious Disease: Target Profiling and Associated Key Assays to Support Vaccine Development from Early Development to Late Clinical Phase

Presented by Luc Gagnon, PhD, Vice President, Vaccines Sciences at Nexelis, a Q² Solutions Company, and Bassam Hallis, PhD, Interim Deputy Director Research and Evaluation at UK Health Security Agency

> More Information

14 Sep 2022
Wed, 14 September 2022

Oligonucleotide Chemistry & Therapeutics Symposium

An intensive 1-day meeting that delves into the latest developments in oligonucleotide synthesis, chemistry, process & analytical development, and therapeutics

> Visit Event Website

29 Nov 2022
Tue, 29 November 2022

Vaccines Europe: In-Person

Bringing together like-minded experts for topical discussions pertaining to vaccines, vaccine research & platform technologies

> Visit Event Website

> See All Upcoming Oxford Global Biologics Events
> See All Webinars & Recordings

Highlights

Peptide Disovery
Insight Article
Peptide Discovery: Unlocking the Future of Disruptive Therapeutics
UCB, Bicycle Therapeutics, and Sanofi share their latest findings in Peptide discovery at Biologics UK 2022.
By Tia Byer |
10 May 2022
Peptides
Discussion Group Report
Advanced Antibody Engineering: AI, ML, and Computational Tools
By Tia Byer |
05 May 2022
Proteins & Antibodies
Insight Article
What’s Next for Antibody-Based Therapeutic Discovery and Optimisation?
By Tia Byer |
25 Apr 2022
Proteins & Antibodies

In-Depth

Peptide Disovery
Insight Article
Peptide Discovery: Unlocking the Future of Disruptive Therapeutics
UCB, Bicycle Therapeutics, and Sanofi share their latest findings in Peptide discovery at Biologics UK 2022.
10 May 2022
Antibody Engineering with AI and ML
Discussion Group Report
Advanced Antibody Engineering: AI, ML, and Computational Tools
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our April Discussion Group addressing ‘Accelerating Antibody Engineering With AI/ML & Advanced Computational Tools and Technologies’ brought together an exclusive panel of key opinion leaders to address the market’s growth and future outlook.
05 May 2022
Targeted Antibody Discovery
Insight Article
What’s Next for Antibody-Based Therapeutic Discovery and Optimisation?
As market leaders in the biologics field, there is no sign of demand for antibody-based therapies slowing down any time soon. With exclusive insights from the CRUK-AstraZeneca Antibody Alliance Laboratory, we look towards the future of antibody discovery and optimisation.
25 April 2022
Sustainable Oligonucleotides
Discussion Group Report
Sustainable Synthesis of Therapeutic Oligonucleotides
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our March Discussion Group addressing ‘Sustainable Synthesis of Therapeutic Oligonucleotides’ brought together an exclusive panel of key opinion leaders to address the market’s growth and future outlook.
21 April 2022
> See All

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login